These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9935146)

  • 1. Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia.
    Petridou E; Dessypris N; Spanos E; Mantzoros C; Skalkidou A; Kalmanti M; Koliouskas D; Kosmidis H; Panagiotou JP; Piperopoulou F; Tzortzatou F; Trichopoulos D
    Int J Cancer; 1999 Feb; 80(4):494-6. PubMed ID: 9935146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I, IGF binding protein 3, and IGFBP protease activity: relation to anthropometric indices in solid tumours or leukaemia.
    Brennan BM; Gill M; Pennells L; Eden OB; Thomas AG; Clayton PE
    Arch Dis Child; 1999 Mar; 80(3):226-30. PubMed ID: 10325701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-3 predicts survival from acute childhood leukemia.
    Petridou E; Skalkidou A; Dessypris N; Moustaki M; Mantzoros C; Spanos E; Trichopoulos D
    Oncology; 2001; 60(3):252-7. PubMed ID: 11340377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.
    Gunnell D; Miller LL; Rogers I; Holly JM;
    Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.
    Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S
    Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
    Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
    J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in concentrations of circulating insulin-like growth factors I and II and binding proteins BP-2 and BP-3 in children treated for acute lymphoblastic leukaemia].
    Krawczuk-Rybak M; Kitszel A; Wołczyński S
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):15-20. PubMed ID: 15355735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between serum Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status and growth parameters in prepubertal cystic fibrosis patients.
    Ozen M; Cokugras H; Ozen N; Camcioglu Y; Akcakaya N
    Pediatr Int; 2004 Aug; 46(4):429-35. PubMed ID: 15310308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 (FGF-21) in obese children: no relationship to growth, IGF-1, and IGFBP-3.
    Reinehr T; Roth CL; Woelfle J
    Horm Mol Biol Clin Investig; 2016 Feb; 30(2):. PubMed ID: 26887040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of childhood and adulthood height and the components of height with insulin-like growth factor levels in adulthood: a 65-year follow-up of the Boyd Orr cohort.
    Bray I; Gunnell D; Holly JM; Middleton N; Davey Smith G; Martin RM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1382-9. PubMed ID: 16434460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous risk factors for childhood leukemia in relation to the IGF system (Greece). The Childhood Haematologists-Oncologists Group.
    Petridou E; Skalkidou A; Dessypris N; Moustaki M; Mantzoros C; Spanos E; Trichopoulos D
    Cancer Causes Control; 2000 Sep; 11(8):765-71. PubMed ID: 11065014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in healthy Thai children and adolescents: relation to age, sex, and stage of puberty.
    Jaruratanasirikul S; Leethanaporn K; Pradutkanchana S; Sriplung H
    J Med Assoc Thai; 1999 Mar; 82(3):275-83. PubMed ID: 10410483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.